Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1998 Apr;227(4):513–518. doi: 10.1097/00000658-199804000-00011

Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.

F Izzo 1, F Cremona 1, F Ruffolo 1, R Palaia 1, V Parisi 1, S A Curley 1
PMCID: PMC1191306  PMID: 9563539

Abstract

OBJECTIVE: We performed this prospective screening trial in chronic hepatitis virus-infected patients to determine the incidence of hepatocellular cancer (HCC) and the resectability and long-term survival rates of these HCC patients. SUMMARY BACKGROUND DATA: Chronic hepatitis B or C virus infection is a major etiologic factor in human HCC. It is not clear if routine screening of chronic viral hepatitis patients improves the survival of patients who develop HCC. METHODS: Screening for HCC was offered to patients chronically seropositive (>5 years) for hepatitis B or C infection. All patients underwent percutaneous core liver biopsy to assess the histologic severity of chronic liver injury. Patients were screened initially and every 3 months thereafter with serum alpha-fetoprotein and transabdominal ultrasound evaluations; HCC was confirmed by needle biopsy of liver tumors. RESULTS: Screening was performed on 1125 hepatitis-positive patients (804 with hepatitis C, 290 with hepatitis B, 31 with both). On liver biopsy, 800 patients had mild chronic active hepatitis and 325 had severe chronic active hepatitis, cirrhosis, or both. Initial screening detected HCC in 61 patients. HCC was detected in six more patients during follow-up; thus, the incidence of HCC was 5.9% (67/1125). However, 66 of the 67 HCC cases (98.5%) arose in the 325 patients with severe chronic active hepatitis or cirrhosis (66/325 [20.3%] vs. 1/800 [0.1%], p < 0.0001 [Wilcoxon signed rank]). Median follow-up of the 67 HCC patients was 24 months. Locally advanced or metastatic, unresectable HCC occurred in 43 patients (64.2%); 24 patients (35.8%), including the 6 patients detected during follow-up screening, underwent margin-negative resection. The median survival for the 24 resected patients was 26 months, compared to 6 months for the 43 patients with unresectable cancer (p < 0.0001, Wilcoxon signed rank). CONCLUSIONS: HCC was found to arise in 20.3% of patients with chronic hepatitis B or C infection and severe liver injury. Initial screening detected resectable lesions in less than half the HCC patients. Routine screening of chronic hepatitis B or C virus-infected patients with ultrasound and alpha-fetoprotein determination should be reserved for patients with severe chronic active hepatitis, cirrhosis, or both.

Full text

PDF
513

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beasley R. P., Hwang L. Y., Lin C. C., Chien C. S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981 Nov 21;2(8256):1129–1133. doi: 10.1016/s0140-6736(81)90585-7. [DOI] [PubMed] [Google Scholar]
  2. Bolondi L., Benzi G., Santi V., Gaiani S., Li Bassi S. L., Zironi G., Mazziotti A., Sama C., Grigioni W., Gozzetti G. Relationship between alpha-fetoprotein serum levels, tumour volume and growth rate of hepatocellular carcinoma in a western population. Ital J Gastroenterol. 1990 Aug;22(4):190–194. [PubMed] [Google Scholar]
  3. Choi T. K., Edward C. S., Fan S. T., Francis P. T., Wong J. Results of surgical resection for hepatocellular carcinoma. Hepatogastroenterology. 1990 Apr;37(2):172–175. [PubMed] [Google Scholar]
  4. Colombo M., de Franchis R., Del Ninno E., Sangiovanni A., De Fazio C., Tommasini M., Donato M. F., Piva A., Di Carlo V., Dioguardi N. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 1991 Sep 5;325(10):675–680. doi: 10.1056/NEJM199109053251002. [DOI] [PubMed] [Google Scholar]
  5. Cottone M., Turri M., Caltagirone M., Maringhini A., Sciarrino E., Virdone R., Fusco G., Orlando A., Marino L., Pagliaro L. Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alfafetoprotein: a prospective study. Hepatogastroenterology. 1988 Jun;35(3):101–103. [PubMed] [Google Scholar]
  6. Curley S. A., Izzo F., Gallipoli A., de Bellis M., Cremona F., Parisi V. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann Surg. 1995 Sep;222(3):375–383. doi: 10.1097/00000658-199509000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Desmet V. J., Gerber M., Hoofnagle J. H., Manns M., Scheuer P. J. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994 Jun;19(6):1513–1520. [PubMed] [Google Scholar]
  8. Haratake J., Takeda S., Kasai T., Nakano S., Tokui N. Predictable factors for estimating prognosis of patients after resection of hepatocellular carcinoma. Cancer. 1993 Aug 15;72(4):1178–1183. doi: 10.1002/1097-0142(19930815)72:4<1178::aid-cncr2820720408>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  9. Ikeda K., Saitoh S., Koida I., Arase Y., Tsubota A., Chayama K., Kumada H., Kawanishi M. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 1993 Jul;18(1):47–53. [PubMed] [Google Scholar]
  10. Ko S., Nakajima Y., Kanehiro H., Hisanaga M., Aomatsu Y., Kin T., Yagura K., Ohyama T., Nishio K., Ohashi K. Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis. Ann Surg. 1996 Nov;224(5):591–595. doi: 10.1097/00000658-199611000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lai E. C., Fan S. T., Lo C. M., Chu K. M., Liu C. L., Wong J. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg. 1995 Mar;221(3):291–298. doi: 10.1097/00000658-199503000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Liaw Y. F., Tai D. I., Chen T. J., Chu C. M., Huang M. J. Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma. Liver. 1986 Jun;6(3):133–137. doi: 10.1111/j.1600-0676.1986.tb00279.x. [DOI] [PubMed] [Google Scholar]
  13. Liaw Y. F., Tai D. I., Chu C. M., Lin D. Y., Sheen I. S., Chen T. J., Pao C. C. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. Gastroenterology. 1986 Feb;90(2):263–267. doi: 10.1016/0016-5085(86)90919-4. [DOI] [PubMed] [Google Scholar]
  14. Maringhini A., Cottone M., Sciarrino E., Marcenó M. P., La Seta F., Fusco G., Rinaldi F., Pagliaro L. Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis. Dig Dis Sci. 1988 Jan;33(1):47–51. doi: 10.1007/BF01536630. [DOI] [PubMed] [Google Scholar]
  15. Nagashima I., Hamada C., Naruse K., Osada T., Nagao T., Kawano N., Muto T. Surgical resection for small hepatocellular carcinoma. Surgery. 1996 Jan;119(1):40–45. doi: 10.1016/s0039-6060(96)80211-x. [DOI] [PubMed] [Google Scholar]
  16. Nomura F., Ohnishi K., Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer. 1989 Oct 15;64(8):1700–1707. doi: 10.1002/1097-0142(19891015)64:8<1700::aid-cncr2820640824>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  17. Sarasin F. P., Giostra E., Hadengue A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. Am J Med. 1996 Oct;101(4):422–434. doi: 10.1016/S0002-9343(96)00197-0. [DOI] [PubMed] [Google Scholar]
  18. Sugioka A., Tsuzuki T., Kanai T. Postresection prognosis of patients with hepatocellular carcinoma. Surgery. 1993 Jun;113(6):612–618. [PubMed] [Google Scholar]
  19. Tanaka H., Hiyama T., Tsukuma H., Fujimoto I., Yamano H., Okubo Y., Kitada A. Cumulative risk of hepatocellular carcinoma in hepatitis C virus carriers: statistical estimations from cross-sectional data. Jpn J Cancer Res. 1994 May;85(5):485–490. doi: 10.1111/j.1349-7006.1994.tb02384.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Thung S. N., Gerber M. A., Sarno E., Popper H. Distribution of five antigens in hepatocellular carcinoma. Lab Invest. 1979 Aug;41(2):101–105. [PubMed] [Google Scholar]
  21. Unoura M., Kaneko S., Matsushita E., Shimoda A., Takeuchi M., Adachi H., Kawai H., Urabe T., Yanagi M., Matsui O. High-risk groups and screening strategies for early detection of hepatocellular carcinoma in patients with chronic liver disease. Hepatogastroenterology. 1993 Aug;40(4):305–310. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES